Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells

Abstract

The transcription factor ThPOK promotes CD4+ T cell differentiation in the thymus. Here, using a mouse strain that allows post-thymic gene deletion, we show that ThPOK maintains CD4+ T lineage integrity and couples effector differentiation to environmental cues after antigenic stimulation. ThPOK preserved the integrity and amplitude of effector responses and was required for proper differentiation of types 1 and 2 helper T cells in vivo by restraining the expression and function of Runx3, a nuclear factor crucial for cytotoxic T cell differentiation. The transcription factor LRF acts redundantly with ThPOK to prevent the transdifferentiation of mature CD4+ T cells into CD8+ T cells. As such, the ThPOK-LRF transcriptional module was essential for CD4+ T cell integrity and responses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Post-thymic ThPOK maintains CD4+ lineage integrity.
Figure 2: ThPOK is not needed for TH17 differentiation.
Figure 3: ThPOK 'protects' TH2 responses.
Figure 4: ThPOK 'protects' TH2 differentiation by restraining Runx functions.
Figure 5: ThPOK antagonism of Runx activity is required for proper TH1 differentiation.
Figure 6: ThPOK is important for CD4+ T cell responses in vivo.
Figure 7: ThPOK and LRF redundantly prevent CD4+ to CD8+ transdifferentiation.

Similar content being viewed by others

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. O'Shea, J.J. & Paul, W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098–1102 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Zhu, J., Yamane, H. & Paul, W.E. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28, 445–489 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Masopust, D., Vezys, V., Wherry, E.J. & Ahmed, R. A brief history of CD8 T cells. Eur. J. Immunol. 37 (suppl. 1), S103–S110 (2007).

    CAS  PubMed  Google Scholar 

  4. Carpenter, A.C. & Bosselut, R. Decision checkpoints in the thymus. Nat. Immunol. 11, 666–673 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Taniuchi, I. et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621–633 (2002).

    CAS  PubMed  Google Scholar 

  6. Woolf, E. et al. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 100, 7731–7736 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. He, X. et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433, 826–833 (2005).

    CAS  PubMed  Google Scholar 

  8. Sun, G. et al. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat. Immunol. 6, 373–381 (2005).

    CAS  PubMed  Google Scholar 

  9. Wang, L. & Bosselut, R. CD4–CD8 lineage differentiation: Thpok-ing into the nucleus. J. Immunol. 183, 2903–2910 (2009).

    CAS  PubMed  Google Scholar 

  10. Wang, L. et al. The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. Immunity 29, 876–887 (2008).

    PubMed  PubMed Central  Google Scholar 

  11. Muroi, S. et al. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate. Nat. Immunol. 9, 1113–1121 (2008).

    CAS  PubMed  Google Scholar 

  12. Egawa, T. & Littman, D.R. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat. Immunol. 9, 1131–1139 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Setoguchi, R. et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822–825 (2008).

    CAS  PubMed  Google Scholar 

  14. Davies, J.M. et al. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18, 365–375 (1999).

    CAS  PubMed  Google Scholar 

  15. Foy, T.M., Aruffo, A., Bajorath, J., Buhlmann, J.E. & Noelle, R.J. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 14, 591–617 (1996).

    CAS  PubMed  Google Scholar 

  16. Carpenter, A.C. et al. The transcription factors Thpok and LRF are necessary and partly redundant for T helper cell differentiation. Immunity 37, 622–633 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Reis, B.S., Rogoz, A., Costa-Pinto, F.A., Taniuchi, I. & Mucida, D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4+ T cell immunity. Nat. Immunol. 14, 271–280 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Djuretic, I.M. et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8, 145–153 (2007).

    CAS  PubMed  Google Scholar 

  19. Naoe, Y. et al. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf β binding to the Il4 silencer. J. Exp. Med. 204, 1749–1755 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Lucas, B., Vasseur, F. & Penit, C. Normal sequence of phenotypic transitions in one cohort of 5-bromo-2′-deoxyuridine-pulse-labeled thymocytes. Correlation with T cell receptor expression. J. Immunol. 151, 4574–4582 (1993).

    CAS  PubMed  Google Scholar 

  21. McCaughtry, T.M., Wilken, M.S. & Hogquist, K.A. Thymic emigration revisited. J. Exp. Med. 204, 2513–2520 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Wang, L. et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4+ T cells. Nat. Immunol. 9, 1122–1130 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Guy-Grand, D. & Vassalli, P. Gut intraepithelial T lymphocytes. Curr. Opin. Immunol. 5, 247–252 (1993).

    CAS  PubMed  Google Scholar 

  24. Taniuchi, I. & Ellmeier, W. Transcriptional and epigenetic regulation of CD4/CD8 lineage choice. Adv. Immunol. 110, 71–110 (2011).

    CAS  PubMed  Google Scholar 

  25. Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006).

    CAS  PubMed  Google Scholar 

  26. Oswald, I.P. et al. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153, 1707–1713 (1994).

    CAS  PubMed  Google Scholar 

  27. Ho, I.C., Tai, T.S. & Pai, S.Y. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat. Rev. Immunol. 9, 125–135 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Pearce, E.L. et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041–1043 (2003).

    CAS  PubMed  Google Scholar 

  29. Cruz-Guilloty, F. et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206, 51–59 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Yagi, R. et al. The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-γ. Immunity 32, 507–517 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Betts, M.R. et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281, 65–78 (2003).

    CAS  PubMed  Google Scholar 

  32. Wildt, K.F. et al. The transcription factor zbtb7b promotes CD4 expression by antagonizing runx-mediated activation of the CD4 silencer. J. Immunol. 179, 4405–4414 (2007).

    CAS  PubMed  Google Scholar 

  33. Grover, H.S. et al. The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden. Infect. Immun. 80, 3279–3288 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhang, D.J. et al. Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene. J. Immunol. 174, 6725–6731 (2005).

    CAS  PubMed  Google Scholar 

  35. Wang, Q., Strong, J. & Killeen, N. Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene. J. Exp. Med. 194, 1721–1730 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Jenkinson, S.R. et al. Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4–CD8 lineage differentiation. J. Exp. Med. 204, 267–272 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Rui, J., Liu, H., Zhu, X., Cui, Y. & Liu, X. Epigenetic silencing of Cd8 genes by ThPOK-mediated deacetylation during CD4 T cell differentiation. J. Immunol. 189, 1380–1390 (2012).

    CAS  PubMed  Google Scholar 

  38. Mucida, D. et al. Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II–restricted cytotoxic T lymphocytes. Nat. Immunol. 14, 281–289 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Zou, Y.R. et al. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat. Genet. 29, 332–336 (2001).

    CAS  PubMed  Google Scholar 

  40. Dupont, C.D., Christian, D.A. & Hunter, C.A. Immune response and immunopathology during toxoplasmosis. Semin. Immunopathol. 34, 793–813 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Reichmann, G. et al. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect. Immun. 68, 1312–1318 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Engel, I., Zhao, M., Kappes, D., Taniuchi, I. & Kronenberg, M. The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cells. Blood 120, 4524–4532 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Liu, Z. et al. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40–CD154 interactions. J. Immunol. 164, 6005–6014 (2000).

    CAS  PubMed  Google Scholar 

  44. Strober, W. & Fuss, I.J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1756–1767 (2011).

    CAS  PubMed  Google Scholar 

  45. Sakaguchi, S. et al. The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes. Nat. Immunol. 11, 442–448 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Xiong, Y. & Bosselut, R. CD4–CD8 differentiation in the thymus: connecting circuits and building memories. Curr. Opin. Immunol. 24, 139–145 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Sattentau, Q.J. & Weiss, R.A. The CD4 antigen: physiological ligand and HIV receptor. Cell 52, 631–633 (1988).

    CAS  PubMed  Google Scholar 

  48. Beaumier, C.M. et al. CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection. Nat. Med. 15, 879–885 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Vinton, C. et al. CD4-like immunological function by CD4 T cells in multiple natural hosts of simian immunodeficiency virus. J. Virol. 85, 8702–8708 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Maeda, T. et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433, 278–285 (2005).

    CAS  PubMed  Google Scholar 

  51. Intlekofer, A.M. et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408–411 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Barnden, M.J., Allison, J., Heath, W.R. & Carbone, F.R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34–40 (1998).

    CAS  PubMed  Google Scholar 

  54. Sun, C.M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775–1785 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Spencer, S.P. et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 343, 432–437 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Oldenhove, G. et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772–786 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank T. Ciucci for experimental assistance and discussions; T.-A. Lewis for animal care and genotyping; M. McGinty and Q. Xiao for technical assistance; X. Wu for microarray analyses; D. Littman, P.P. Pandolfi and S. Reiner for mice; M. Grigg for the T. gondii strain; J. Grainger, T. Hand and S. Spencer for discussions; and J. Ashwell and J. Brenchley for reading the manuscript. Supported by the US National Institutes of Health Intramural Research Programs of the National Cancer Institute, Center for Cancer Research, the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Author information

Authors and Affiliations

Authors

Contributions

M.S.V., L.W., Y.B. and R.B. designed the research; M.S.V., L.W., N.B, A.C.C., Y.X., L.C.W. and E.W. performed and analyzed experiments; K.-D.S. and P.E.L. constructed and provided CD2-Cre mice; R.B. supervised the research; M.S.V. and R.B. wrote the manuscript.

Corresponding author

Correspondence to Rémy Bosselut.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Analyses of resting cell populations in Thpokpd mice.

(a) Percentage of Rosa26YFP-expressing cells among CD4 or CD8SP thymocytes (Th) or spleen T cells (Spl) from CD2-Cre transgenic mice. (b,c) Plots indicate numbers (× 106) of total thymocytes (b, top), gated thymocytes (b, bottom three rows) and gated splenocytes (c). Each symbol represents one 6–8 week-old mouse. (ac) Data are representative of four independent experiments. Thpok +/+ and Thpokpd mice are littermates to control for background effects. Significance was determined by Student’s t-test (*, P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, not significant in other cases). (d) Percent of Rosa26YFP-expressing cells among Foxp3-expressing CD4SP thymocytes or CD4+ spleen T cells from Thpokpd mice. Each symbol represents one mouse; data are from three experiments. (e) Immunoblot analysis of Runx protein expression in sorted spleen naïve CD4+ or CD8+ T from Thpokpd or Thpok+/+ littermate mice. The same membrane was subsequently stripped and reprobed for β-actin expression to evaluate lane loading. Representative of three independent experiments. (f) Contours plots show CD4 versus CD8 expression on total (left) or TCRβhiCD24lo (right) thymocytes from 6–9 week-old littermate mice of the indicated genotype. Representative of three experiments. (g) Absolute numbers of mature (TCRhi CD24lo) CD4SP thymocytes in mice of the indicated genotype. Each symbol represents one mouse. No significant difference among genotypes.

Supplementary Figure 2 TH17 differentiation of Thpokpd cells.

(a,b) Graphs show cumulative results for colon length (a) and mouse weight (b) from two independent C. rodentium infection experiments. Mean ± s.e.m. is shown. Each symbol represents a mouse. No significance by t-test. (c) ELISA quantification of IL-17 secretion by Thpokpd and Thpok+/+ cells activated under non-polarizing (THN), TH1 or TH17 conditions. Each symbol represents a separate culture. Data are from three mice of each genotype analyzed separately. Bars indicate mean ± s.e.m. No significance by t-test between Thpok+/+ and Thpokpd. (d) Histograms show GzmB expression in T effector cells obtained after 5-day cultures in TH17 conditions of sorted CD4+CD44lo spleen T cells from Thpok+/+ (solid grey) or Thpokpd (plain line) mice. The dashed line histogram shows GzmB expression on wild-type CD8+ effector cells cultured under THN conditions. Representative of three independent experiments.

Supplementary Figure 3 TH2 differentiation of Thpokpd cells.

(a) ELISA quantification of IL-4 secretion by Thpokpd and Thpok+/+ cells activated under nonpolarizing conditions as in Fig. 3e. Each symbol represents a separate culture. Data are from three distinct sorting experiments, each with a distinct mouse from each genotype. The average IL-4 concentrations were 0.17 ng/ml for Thpok+/+ cells and <0.01 ng/ml for Thpokpd cells (*P < 0.005 by paired t-test). (b) Scatter plots show the percentage of IL-4 or IFNγ producers among Thpokpd or Thpok+/+ cells cultured under non polarizing conditions as in Fig. 3e. Each symbol represents a culture derived from a single mouse. Statistical significance was determined by t-test (*P < 0.005; **P < 10–4).

Supplementary Figure 4 Functional relationships between ThPOK and Eomes and Cbfβ.

(a) Scatter plots show the percentage of IL 4- or IFNγ-producing cells among Thpok+/+, Thpokpd, Thpokpd Cbfbpd or Thpokpd Eomespd cells cultured under nonpolarizing conditions as in Fig. 3e. Each symbol represents a culture derived from a single mouse. Statistical significance was determined by t-test (*P <0.05; **P < 0.025; ***P < 0.01) on pooled data from three independent experiments. Contours plots (b) show CD4 versus CD8 expression on total (left) or TCRβhiCD24lo (center) thymocytes, or on TCRβ+ spleen cells (right) from 5 week old Thpok+/+Eomes+/+, Thpokpd Eomes+/+ or ThpokpdEomespd mice. Representative of three or four mice for each genotype from two independent experiments. (c) Graphs show the absolute numbers of CD4+CD8 and CD8+ T cells in the spleens from mice shown in b. There was no significant difference in the size of either subset among the three genotypes.

Supplementary Figure 5 Analyses of gene expression in Thpokpd effector cells.

(a) Contour plots show CD8 versus CD4 expression in Thpok+/+ and Thpokpd effector T cells derived from naïve CD4+CD8 cells as in Fig. 5b. (b) Heat map indicates relative expression (log2 values) on genes with 3-fold or greater change in expression in Thpokpd CD4+CD8+ vs. wild-type CD4+CD8 effector T cells.

Supplementary Figure 6 Post-thymic ThPOK restrains cytotoxic gene expression during in vivo TH1 responses.

(a) Contour plots assess uninfected (left) or day 10-infected (right) Thpok+/+ or Thpokpd spleen CD4+ T cells for expression of intra-cellular IFN-γ versus IL-17A. (b) Parasite load was quantified as percentage of RFP+ splenocytes in mice infected with RFP-expressing T. gondii. Each symbol represents one mouse; data are from two independent experiments. No significant difference by t-test. (c) Contour plots of Eomes versus T-bet expression in spleen CD4+ T cells from uninfected (left) or day 10-infected (right) Thpok+/+ or Thpokpd mice. Data (a,c) are representative of three experiments for each panel.

Supplementary Figure 7 Overlapping functions of LRF and ThPOK in CD4 expression.

(a) Histogram overlays show CD4 expression on sorted CD4lo (1), CD4+ CD8 (2) CD44lo spleen T cells from Thpokpd mice or their Thpok+/+ CD4+ CD8- counterparts (3) ex vivo (left panel), or after 5 d culture under TH1 conditions (right). Representative of three experiments. (b,c) Contours plots assess 6–8-week-old littermates of the indicated genotype for expression of CD4 and CD8 on total (left) and TCRβhiCD24lo (right) thymocytes (b), or (c) on total (left) or gated TCR+ YFP+ CD44lo (right) spleen T cells. Figures are representative of three experiments, summarized in d. (d) Plot summarizes numbers (× 106) of mature (TCRhi CD24lo) CD4 and CD8SP thymocytes (top) and of CD4+ (including CD4lo and pDP) and CD8+ T cells from 6–8 week-old mice of the indicated genotype. Significance was determined by Student’s t-test (*P < 0.05, ** P < 0.01; not significant otherwise). (e) Immunoblot analysis of Runx protein expression in effector T cells obtained after 5-d culture under TH1 conditions from naïve CD8+ T cells from Thpok+/+ Zbtb7a+/+ mice or CD4+ T cells from Thpokpd Zbtb7a+/+ or Thpokpd Zbtb7apd mice. The same membrane was subsequently stripped and reprobed for β-actin expression to evaluate lane loading. Representative of two immunoblots.

Supplementary information

Supplementary Text and Figures

Supplementary figures 1–7 (PDF 1170 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vacchio, M., Wang, L., Bouladoux, N. et al. A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells. Nat Immunol 15, 947–956 (2014). https://doi.org/10.1038/ni.2960

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.2960

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing